Daewoong Pharmaceutical Co. LTD.: all 225 studies

Page 2 of 3. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.

• Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of SarpogrelateCompletedNCT05083299
• Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With GastritisCompletedNCT05072938Phase 4
• Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)CompletedNCT04926623Not applicable
• To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy VolunteersCompletedNCT04888728Phase 1
• To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy VolunteersCompletedNCT04888715Phase 1
• Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult VolunteersStatus unknownNCT04827472Phase 1
• Pharmacokinetics and Safety of DWJ1451 in Healthy AdultsStatus unknownNCT04819932Phase 1
• Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic UlcerCompletedNCT04784910Phase 3
• Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy VolunteersCompletedNCT04782505Phase 1
• Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507Status unknownNCT04772443Phase 3
• To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult VolunteersCompletedNCT04767815Phase 1
• To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.CompletedNCT04749173Phase 1
• A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2TerminatedNCT04721535Phase 3
• Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 PatientsTerminatedNCT04713176Phase 3
• The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes MellitusCompletedNCT04654390Phase 3
• The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.CompletedNCT04634500Phase 3
• The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.CompletedNCT04632862Phase 3
• Treatment Effect According to Timing of Administration of DWP14012 40 mgStatus unknownNCT04613895Not applicable
• To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003Status unknownNCT04592835Phase 1
• To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)TerminatedNCT04541485Phase 1
• To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19Status unknownNCT04524052Phase 1
• Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the PlaceboTerminatedNCT04521296Phase 2/3
• Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDsStatus unknownNCT04490434Phase 1
• Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy VolunteersStatus unknownNCT04477369Phase 1
• Effects of Food on the Pharmacokinetics of DWJ1458 in Healthy AdultsWithdrawnNCT04393597Phase 1
• Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male AdultsStatus unknownNCT04343547Phase 1
• Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic GastritisCompletedNCT04341454Phase 3
• Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive EsophagitisStatus unknownNCT04341428Phase 3
• Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy VolunteersCompletedNCT04328766Phase 1
• Efficacy and Safety of DWP450 in Subjects With Benign Masseteric HypertrophyCompletedNCT04294251Phase 3
• Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male VolunteersCompletedNCT04278391Phase 1
• Type 2 Diabetes Patients With Renal ImpairmentStatus unknownNCT04221399Phase 1
• Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III)Status unknownNCT04185805Phase 1
• Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)Status unknownNCT04167267Phase 1
• Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451Status unknownNCT04161001Phase 3
• Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy VolunteersCompletedNCT04159961Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX TabCompletedNCT04120753Phase 4
• Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)CompletedNCT04064073Phase 1
• Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes MellitusStatus unknownNCT04014023Phase 2
• Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy VolunteersStatus unknownNCT04003441Phase 1
• Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed ConditionsStatus unknownNCT03947528Phase 1
• Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting ConditionsCompletedNCT03947489Phase 1
• Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental FatCompletedNCT03946592Phase 3
• Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux DiseaseStatus unknownNCT03811080Phase 3
• Clinical Trial to Investigate the Efficacy and Safety of DWJ1351CompletedNCT03753477Phase 1
• Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)CompletedNCT03736369Phase 3
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and KoreanCompletedNCT03574415Phase 1
• A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding ConditionsCompletedNCT03574285Phase 1
• A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting ConditionsCompletedNCT03573622Phase 1
• A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed ConditionsCompletedNCT03512821Phase 1
• A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting ConditionsCompletedNCT03512808Phase 1
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male SubjectsCompletedNCT03487562Phase 1
• Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B PatientsCompletedNCT03485534Phase 4
• DWP450 Treatment in Subjects With Benign Masseteric HypertrophyStatus unknownNCT03369990Phase 2
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male VolunteersCompletedNCT03364985Phase 1
• Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental FatCompletedNCT03224117Phase 2
• Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With GastritisTerminatedNCT03184415Phase 3
• Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)CompletedNCT03184402Phase 3
• Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)Status unknownNCT03184363Phase 3
• Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)CompletedNCT03184324Phase 2
• Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate CancerStatus unknownNCT03029533Phase 1
• Efficacy and Safety of DWJ1252 in the Treatment of Functional DyspepsiaCompletedNCT03024086Phase 3
• Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male VolunteersStatus unknownNCT03016520Phase 1
• Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy SubjectsStatus unknownNCT03016494Phase 1
• Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and DyslipidemiaStatus unknownNCT03009721
• A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and HyperlipidemiaCompletedNCT03009487Phase 3
• Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy VolunteersStatus unknownNCT03005223Phase 1
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)CompletedNCT02988362Phase 1
• Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) DiseaseStatus unknownNCT02953405
• Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy VolunteersCompletedNCT02952755Phase 1
• Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy SubjectsCompletedNCT02952547Phase 1
• Safety and Efficacy of NABOTA in Treatment of Essential BlepharospasmCompletedNCT02947815Phase 2/3
• Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)CompletedNCT02947620Phase 3
• Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy VolunteersCompletedNCT02947139Phase 1
• Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning PatientsStatus unknownNCT02946450
• Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total ThyroidectomyStatus unknownNCT02909270Phase 3
• Efficacy and Safety of DWP450 for the Treatment of Crows Feet LinesStatus unknownNCT02882893Phase 2/3
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male VolunteersCompletedNCT02757144Phase 1
• Phase 1 Study for Safety and Tolerability of HL036CompletedNCT02717208Phase 1
• Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy SubjectsCompletedNCT02704559Phase 1
• Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone DeficiencyCompletedNCT02693522Phase 3
• Study of DWJ1351 in Healthy Male VolunteersStatus unknownNCT02665832Phase 1
• A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer PatientsStatus unknownNCT02648906Phase 4
• A Multiple Dose Study of DWP10292 and UDCA in Healthy Male SubjectsCompletedNCT02622685Phase 1
• Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar LinesCompletedNCT02568150Phase 4
• A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy VolunteersStatus unknownNCT02561884Phase 1
• A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152CompletedNCT02502721Phase 1
• Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric CancerCompletedNCT02490111Phase 3
• A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 'Ursa Complex Soft Cap. (UDCA-004)' in Patients With Physical Fatigue.CompletedNCT02418130Phase 4
• Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver DysfunctionCompletedNCT02415777Phase 4
• Comparative Bioavailability Study of UDCACompletedNCT02385032Phase 1
• Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male VolunteersCompletedNCT02369302Phase 1
• Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult VolunteersCompletedNCT02332044Phase 1
• Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult VolunteersCompletedNCT02089399Phase 1
• Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)WithdrawnNCT02069717
• Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male VolunteersCompletedNCT01964365Phase 1
• A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb SpasticityCompletedNCT01945684Phase 3
• Pharmacokinetic Interactions and Safety Study of Telmisartan and ChlorthalidoneCompletedNCT01806363Phase 1
• A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male SubjectsCompletedNCT01806324Phase 1
• Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mgCompletedNCT01806311Phase 1

← Daewoong Pharmaceutical Co. LTD. overview and focus areas